PHOTOPHARMICS
PhotoPharmics is a clinical-stage medical device company developing next-generation treatments for treating neurodegenerative disorders through the eyes. We have 30+ years of research and experience in specialized phototherapy. We previously developed specialized solutions now widely used to regulate circadian rhythms for seasonal affective disorder, sleep disorders, anxiety, and depression (acquired by Philips-Respironics in 2007). We are currently extending our research into several other neurodegenerative diseases. We aim to make a clinically meaningful difference in patients’ lives by delivering safe and effective treatments.
PHOTOPHARMICS
Industry:
Biotechnology Health Care Life Science Medical Medical Device Pharmaceutical
Founded:
2011-01-01
Address:
American Fork, Utah, United States
Country:
United States
Website Url:
http://www.photopharmics.com
Total Employee:
1+
Status:
Active
Contact:
801-770-6960
Email Addresses:
[email protected]
Total Funding:
15.76 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics
Similar Organizations
CPR Therapeutics
CPR Therapeutics is a medical device company developing the next-generation system for cardiopulmonary resuscitation.
Osteal Therapeutics
Osteal Therapeutics is a clinical stage specialty pharmaceutical company developing novel treatments for orthopedic infections.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Kickstart
Kickstart investment in Convertible Note - PhotoPharmics
PC Squared, LLC
PC Squared, LLC investment in Debt Financing - PhotoPharmics
Kickstart
Kickstart investment in Seed Round - PhotoPharmics
PC Squared, LLC
PC Squared, LLC investment in Seed Round - PhotoPharmics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-08-31 | PhotoPharmics Appoints Dr. Karl Kieburtz as Chief Medical Officer |
Official Site Inspections
http://www.photopharmics.com
- Host name: plesk1.photopharmics.com
- IP address: 54.196.30.232
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "PhotoPharmics"
About Us - PhotoPharmics
PHOTOPHARMICS, INC. 3451 North Triumph Boulevard, Suite 201 Lehi, UT 84043 USA. Phone +1 (801) 770-6960See details»
PhotoPharmics - Crunchbase Company Profile & Funding
PhotoPharmics is a clinical-stage medical device company developing next …See details»
PhotoPharmics, Inc - LinkedIn
PhotoPharmics, Inc | 733 followers on LinkedIn. An Emerging Breakthrough for Parkinson's Disease | PhotoPharmics specialize in treating neurodegenerative disorders through the eyes. …See details»
PhotoPharmics 2025 Company Profile: Valuation, Funding
PhotoPharmics was founded in 2011. Where is PhotoPharmics headquartered? PhotoPharmics is headquartered in Lehi, UT. What is the size of PhotoPharmics? PhotoPharmics has 9 total …See details»
PhotoPharmics - Leadership Team - The Org
The Leadership Team at PhotoPharmics is responsible for setting the strategic direction of the company, driving innovation in the development of medical devices for neurodegenerative …See details»
PhotoPharmics, Inc. Company Profile | Lehi, UT | Competitors ...
Find company research, competitor information, contact details & financial data for PhotoPharmics, Inc. of Lehi, UT. Get the latest business insights from Dun & Bradstreet.See details»
Photopharmics - VentureRadar
PhotoPharmics is a clinical-stage therapeutic device company developing next-generation treatments for addressing neurodegenerative disorders through the eyes. We previously …See details»
Newsroom - PhotoPharmics
Dec 5, 2024 Developed by PhotoPharmics, this non-invasive, at-home light therapy is designed to help improve non-motor symptoms like sleep disturbances, fatigue, and mood …See details»
PhotoPharmics Secures $6M for Parkinson’s Light Therapy Trial
Apr 21, 2025 PhotoPharmics Advances Light-Based Therapy for Parkinson’s with Phase 3 Trial and New Investment. PhotoPharmics, a privately held, clinical-stage medical device company, …See details»
PhotoPharmics - Contacts, Employees, Board Members, Advisors …
PhotoPharmics is a medical device company that develops treatments for treating neurodegenerative disorders. New. ... Experience the new Crunchbase, powered by AI . …See details»
PhotoPharmics strengthens executive team – Utah Business
1 day ago PhotoPharmics is a privately held, clinical-stage medical device company developing next-generation therapies for treating neurodegenerative disorders through the eyes. …See details»
PhotoPharmics - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
Investors - PhotoPharmics
Dec 20, 2024 PHOTOPHARMICS, INC. 3450 North Triumph Boulevard Lehi, UT 84043 USA. Phone +1 (801) 770-6960See details»
PhotoPharmics - Updates, News, Events, Signals & Triggers
Aug 31, 2020 PhotoPharmics is a clinical-stage medical device company developing next-generation treatments for treating neurodegenerative disorders. New. Resources. Advanced …See details»
Answering some common questions about PhotoPharmics
Jun 15, 2021 PHOTOPHARMICS, INC. 3450 North Triumph Boulevard, Suite 141 Lehi, UT 84043 USA. Phone +1 (801) 770-6960See details»
PhotoPharmics Enrolls First 25 Patients in Pivotal Parkinson’s …
May 13, 2024 PhotoPharmics, the leader in specialized phototherapy for neurodegenerative diseases, today announced the successful enrollment of its first 25 patients into the Celeste …See details»
PhotoPharmics Brings Renowned Experts in Parkinson’s
Sep 16, 2021 PhotoPharmics is a privately held, clinical-stage medical device company developing next-generation treatments for treating neurodegenerative disorders through the …See details»
PhotoPharmics brings renowned experts in Parkinson’s disease …
Clinical-stage medical device maker PhotoPharmics today announced a Clinical & Scientific Advisory board (CSAB) comprised of six leading experts in Parkinson’s disease (PD) and …See details»
PhotoPharmics reaches a third of enrolment goal for PD light …
Aug 9, 2024 PhotoPharmics’ technology uses phototherapy to target photoreceptors in the eyes responsible for circadian rhythm – the day-by-day biological cycles that help many bodily …See details»
Science - PhotoPharmics
PhotoPharmics has combined the wavelengths of light that are most efficient in stimulating the mRGCs in PD and created a novel light technology aimed at restoring normal retinal signaling …See details»